- 6-12 months of multimodal treatment
- 6-8 weeks after surgery, ongoing during chemotherapy
- 84%
China versus the U.S.
- China clinical rate
- $20,000 – $60,000
- $40,000
- United States
- $100,000 – $400,000
- $250,000
- You save
- ~84%
- $210,000 per procedure
Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.
What the procedure involves.
Mesothelioma treatment in China employs a multimodal approach combining radical surgery (pleurectomy/decortication or extrapleural pneumonectomy), chemotherapy with pemetrexed/cisplatin, and emerging immunotherapy combinations. Chinese thoracic oncology centers have growing expertise due to historical asbestos exposure cases, with access to clinical trials for novel treatments including checkpoint inhibitors. Hyperthermic intrathoracic chemotherapy (HITHOC) is available at select specialized centers.
Step by step.
Diagnosis & Staging
Thoracoscopic biopsy, PET-CT staging, and pulmonary function testing to assess operability
Neoadjuvant Chemotherapy
2-4 cycles of pemetrexed/cisplatin to reduce tumor burden before surgery
Radical Surgery
Pleurectomy/decortication or EPP to remove all visible tumor from the chest cavity
Adjuvant Therapy
Additional chemotherapy, radiation, or immunotherapy based on pathological response
- Access to multimodal treatment at specialized thoracic centers
- Availability of emerging immunotherapy combinations
- Significantly lower treatment costs than Western countries
- Clinical trial access for novel therapeutic approaches
- Aggressive disease with challenging prognosis
- Major surgery carries significant morbidity
- Chemotherapy toxicity including renal and bone marrow effects
- High recurrence rates even with optimal treatment
Ask the AI for hospitals that handle mesothelioma treatment.
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.